@Bob:
JM has shown with the 'blind' results that she cant repeat her own PCR results unless she knows what the answer 'should' be. We know that she has been unwilling to let anyone else have access to her experimental materials to make independent tests for contamination. We know that she failed to reveal a key experimental detail, the 5AZA treatment, this we do know can cause exactly the kind of artifacts that she is reporting as results, and that in the one place she revealed that usage, she did not do the key control, for those artifacts.
.
Isn't it being reported that not all of the ONLY 15 patient samples in the blood working group study were actually tested at the WPI/Mikovits. I'm hearing some of the samples were tested at Vipdx . Mikovits does not and has not fealt comfortable with the Vipdx testign accuracy. So is the issue that the Vipdx testing is not accurate but the WPI testing was? It seems at least a possiblity? Also only 15 samples? That does not provide much power. An how many of those 15 were tested at the WPI and how many at Vipdx? I'm hoping the Lipkin study proceeds and can sort out the mess.